P040 Compassionate use triple therapy CFTR modulation (Kaftrio®) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability

Autor:	M. McCarthy, C. Howlett, D. Morrissy, S. Twohig, Desmond M. Murphy, Barry J. Plant, Tamara Vagg, C. Fleming, Yvonne McCarthy, J. Dorgan
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine medicine.medical_specialty medicine.drug_class business.industry Antibiotics medicine.disease Cystic fibrosis Pulmonary embolism Sepsis Clinical trial Tolerability Internal medicine Pediatrics Perinatology and Child Health Cohort medicine Liver function business
Zdroj:	Journal of Cystic Fibrosis. 20:S50-S51
ISSN:	1569-1993
DOI:	10.1016/s1569-1993(21)01067-5
Popis:	Objective: Patients (F508del/F508del or F508del/MF) with severe CF (ppFEV1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::08b8a35386fbdf600c2871d111ed0648 https://doi.org/10.1016/s1569-1993(21)01067-5 Zobrazit plný text záznamu Full Text from ScienceDirect